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The coronavirus mouse hepatitis virus (MHV) directs the synthesis of viral RNA on discrete membranous complexes that
are distributed throughout the cell cytoplasm. These putative replication complexes are composed of intimately associated
but biochemically distinct membrane populations, each of which contains proteins processed from the replicase (gene 1)
polyprotein. Specifically, one membrane population contains the gene 1 proteins p65 and p1a-22, while the other contains the
gene 1 proteins p28 and helicase, as well as the structural nucleocapsid (N) protein and newly synthesized viral RNA. In this
study, immunofluorescence confocal microscopy was used to define the relationship of the membrane populations com-
prising the putative replication complexes at different times of infection in MHV-A59-infected delayed brain tumor cells. At
5.5 h postinfection (p.i.) the membranes containing N and helicase colocalized with the membranes containing p1a-22/p65
at foci distinct from sites of M accumulation. By 8 to 12 h p.i., however, the membranes containing helicase and N had a
predominantly perinuclear distribution and colocalized with M. In contrast, the p1a-22/p65-containing membranes retained
a peripheral, punctate distribution at all times of infection and did not colocalize with M. By late times of infection, helicase,
N, and M each also colocalized with ERGIC p53, a specific marker for the endoplasmic reticulum–Golgi–intermediate
compartment. These data demonstrated that the putative replication complexes separated into component membranes that
relocalized during the course of infection. These results suggest that the membrane populations within the MHV replication
complex serve distinct functions both in RNA synthesis and in delivery of replication products to sites of virus assembly.
© 2001 Academic Press
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The coronavirus mouse hepatitis virus, strain A59
(MHV-A59), contains a 32-kb, single-stranded, positive-
sense RNA genome. The MHV replicase gene (gene 1)
encodes two coamino-terminal polyproteins that are pro-
teolytically processed to yield at least 15 mature proteins
(Fig. 1) (Denison et al., 1998; Lu et al., 1998; Ziebuhr and
Siddell, 1999). Inhibition of gene 1 polyprotein process-
ing at any time during infection has been shown to inhibit
viral RNA synthesis (Kim et al., 1995), demonstrating an
essential role for proteolytically mature gene 1-encoded
proteins in coronavirus replication and transcription.
Studies of temperature-sensitive mutants of MHV have
also implicated these proteins in viral RNA synthesis
(Baric et al., 1990; Leibowitz et al., 1982; Schaad et al.,
990). Yet, most of the MHV replicase gene products
ave no defined functions or sequence homology to
nown viral or cellular proteins.
Studies of the localization and interactions of MHV
1 To whom correspondence and reprint requests should be ad-
ressed at Department of Pediatrics, Vanderbilt University Medicalt
i
enter, D7235 MCN, Nashville, TN 37232-2581. Fax: (615) 343-9723.
-mail: mark.denison@mcmail.vanderbilt.edu.
21eplicase proteins in infected cells have provided critical
nsights into the possible roles for these proteins during
iral replication. The localization of replicase gene-en-
oded proteins to cytoplasmic foci active in viral RNA
ynthesis has been well documented (Bi et al., 1995,
998; Bost et al., 2000; Denison et al., 1999; Heusipp et
al., 1997; Schiller et al., 1998; Shi et al., 1999; van der
eer et al., 1999; Ziebuhr and Siddell, 1999). In addition,
ecent confocal microscopy studies have determined
hat multiple replicase gene proteins are colocalized in
hese foci at 6.5 h postinfection (p.i.) (Bost et al., 2000).
ell fractionation experiments have demonstrated asso-
iation of the colocalized gene 1-encoded proteins with
wo membrane populations of distinct density on iodixa-
ol gradients (Sims et al., 2000). The less dense mem-
rane population was LAMP-1 (lysosome-associated
embrane protein 1) positive and contained the p65 and
1a-22 proteins (Sims et al., 2000). In contrast, the more
ense population contained markers for ER as well as
AMP-1-positive membranes. The dense population was
ssociated with the viral helicase (hel), p28, and nucleo-
apsid (N) proteins (Sims et al., 2000). In addition, the
el/p28/N-positive membranes contained almost all ofhe viral RNA synthesized between 6 and 8 h p.i. Finally,
t has been shown that the putative replication com-
0042-6822/01 $35.00
Copyright © 2001 by Academic Press
All rights of reproduction in any form reserved.
gions o
lated r
22 BOST, PRENTICE, AND DENISONplexes were almost entirely discrete from sites of M
accumulation (Bost et al., 2000). Together, these data
suggested that the putative MHV replication complex is
multipartite, composed of closely associated membrane
populations containing hel/N/p28/RNA and p1a-22/p65,
respectively (Sims et al., 2000), and that the multipartite
complexes were distinct from sites of virion assembly.
For simplicity in the current report, the term “complex” will
be used to refer to colocalized proteins contained in the
discrete membrane populations.
In this study we sought to determine whether the hel/N
complexes remain associated with the p1a-22/p65 com-
plexes throughout the infectious cycle in delayed brain
tumor (DBT) cells. Experiments were performed to deter-
mine whether the localization of the hel/N complexes
was altered with respect to the p1a-22/p65 complexes
and sites of virion assembly during the course of infec-
tion. We demonstrate that the hel/N complexes were
extensively colocalized with the p1a-22/p65 complexes
at 5.5 h p.i., but by 8 h p.i. the hel/N complexes colocal-
ized with M while the p1a-22/p65 complexes were still
detected as peripheral foci entirely distinct from sites of
M accumulation. The results of this study suggest that
the multipartite nature of the putative MHV replication
complex has an important biological implication; the abil-
ity to separate into two complexes and translocate one of
these complexes to sites of virus budding at late times of
infection.
RESULTS
The hel/N complex relocalizes to sites of M
accumulation at late times of infection
Using hel as a marker for the hel/N/p28/RNA com-
plexes and M as a marker for sites of virion assembly, we
sought to determine whether the localization of hel/N
complexes changed during the course of infection. DBT
FIG. 1. MHV-A59 genome organization, replicase protein domains,
MHV-A59 is shown. The overlapping open reading frames (ORFs 1a a
mature proteins processed from the gene 1 replicase polyproteins is
expressing the M and N proteins are shown by hatched boxes. Mature
boxes. The black rectangles underneath the schematic represent re
polyclonal antisera (anti-p65, anti-p1a-22, and B1/ahel). NTR, nontranscells were mock-infected or infected with MHV-A59 for
5.5, 8, or 12 h and probed with antibodies directedagainst hel (B1) and M (J.1.3), followed by analysis using
confocal immunofluorescence microscopy (Fig. 2). These
times were chosen since we have previously shown that
the rate of MHV RNA synthesis is maximal at 5 to 6 h p.i.
in DBT cells and production of progeny virus is still active
at 12 h p.i. (Kim et al., 1995).
Neither hel, M, nor N was detected in mock-infected
DBT cells (Fig. 2A). In MHV-infected cells, hel and M
were distinct at 5.5 h p.i., with hel detected as punctate
cytoplasmic foci and M as a typical perinuclear “cap.”
However, when cells were probed at 8 and 12 h p.i., hel
and M were no longer distinct, but rather were exten-
sively colocalized (Figs. 2B and 2C). The colocalization of
hel and M was detected in a more prominent perinuclear
pattern similar to that seen with M alone at 5.5 h p.i.
Although the degree of hel/M colocalization varied from
cell to cell in the infected monolayer at each time point,
the number of cells with significant hel/M colocalization
increased between 6 and 8 h p.i. (data not shown). Hel/M
colocalization was predominant by 12 h p.i. We therefore
chose 5.5 and 12 h p.i. as the early and late time points
for subsequent experiments.
To determine whether hel was relocalizing indepen-
dent of the complexes containing hel, N, and viral RNA,
we investigated whether other components of the com-
plex also relocalized at sites of M accumulation by 12 h
p.i. Nucleocapsid protein was chosen since it has pre-
viously been shown to colocalize with hel by both con-
focal immunofluorescence and biochemical fractionation
(Denison et al., 1998; Sims et al., 2000). When a direct
comparison of N and hel localization was performed at
5.5 h p.i., hel and N colocalized in punctate cytoplasmic
foci (Fig. 2C), in agreement with our previous results
(Denison et al., 1998). When cells were probed for hel
and N at 12 h p.i., hel and N retained their colocalization
both in single cells and in syncytia (Fig. 2C). This result
suggested that both hel and N were relocalizing in intact
tibodies. The schematic of the 32-kb positive-strand RNA genome of
are shown by arrows. The complete pattern of known and predicted
as domains demarcated by vertical lines. The regions of the genome
ase gene products discussed in this article are indicated by the black
f gene 1 expressed as recombinant proteins and used to generate
egion; hel, helicase; M, membrane protein; N, nucleocapsid.and an
nd 1b)
shown
repliccomplexes at late times of infection. To demonstrate this
directly, the localization of N with respect to M was
f
(
L
1
Colocalization of N (green) and hel (red) at 5.5 and 12 h p.i. Yellow pixels in right panels show coincidence of signal (D). Colocalization of N (green)
and M (red) at 5.5 and 12 h p.i.
23TRANSLOCATION OF MHV REPLICASE PROTEINSFIG. 3. p1a-22 and p65 do not relocalize during MHV infection. MHV-A59-infected DBT cells were fixed and permeabilized at 5.5 or 12 h and probed
or M (red in all panels) and for either p1a-22 or p65 (green). Yellow pixels in merged images indicate areas of coincidence of red and green signal.
A) Mock-infected DBT cells probed for p1a-22 and M (p1a-22/M) or p65 and M (p65/M). Images are merged red, green, and DIC images. (B)FIG. 2. Relocalization of hel/N complexes in MHV-infected DBT cells. MHV-A59-infected DBT cells were fixed and permeabilized at the times
indicated (5.5, 8, or 12 h p.i.) and dual labeled. Yellow pixels in merged images indicate areas of coincidence of red and green signal. (A) Mock-infected
DBT cells probed for hel (green) and M (red) (hel/M) or N (green) and M (red) (N/M). Red, green, and DIC images are merged to show cell morphology.
(B) Localization of hel (green) and M (red) at 5.5, 8, and 12 h p.i. Images include DIC image to show morphology and lack of nuclear localization. (C)ocalization of p1a-22 (green) and hel (red) at 5.5 h p.i. (C) Localization of p1a-22 and M at 5.5 and 12 h p.i. (D) Localization of p65 and M at 5.5 and
2 h p.i.
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24 BOST, PRENTICE, AND DENISONanalyzed at 5.5 and 12 h p.i. At 5.5 h p.i., foci of N were
entirely distinct from sites of M concentration, but by 12 h
p.i., N was extensively colocalized with M in perinuclear
foci, in a pattern indistinguishable from that with hel and
M. The N/M colocalization was observed both in individ-
ual cells (data not shown) and in syncytia. Together
these results demonstrated that the intact membranous
complexes containing hel and N were relocalized to
sites of M accumulation.
The hel/N complexes and p1a-22/p65 complexes
separate at late times of infection
We next sought to determine whether the hel/N com-
plexes remained associated with the p1a-22/p65 com-
plexes throughout infection. MHV-infected cells were
fixed at 5.5 and 12 h p.i. and localization of p1a-22 and
p65 with respect to M was determined in dual-labeling
experiments (Fig. 3). In mock-infected cells, no signal
was detected with ap1a-22 or ap65, confirming the spec-
FIG. 4. Cycloheximide does not inhibit hel/N complex relocalization.
MHV A59-infected DBT cells were treated with cycloheximide begin-
ning at 5.5 h p.i. continuously until 12 h p.i., when cells were fixed and
permeabilized. Cells were then probed for (A) hel and M; (B) N and M;
(C) p1a-22 and M; or (D) p65 and M. M is red in all panels. Yellow pixels
in merged images indicate areas of coincidence of red and green
signal.ficity of the antibodies (Fig. 3A). In MHV-infected cells,
e first demonstrated that p1a-22 and hel colocalizedxtensively at 5.5 h p.i., a result consistent with our
revious studies (Fig. 3B) (Bost et al., 2000). When p1a-22
and M were directly compared at 5.5 h p.i., p1a-22 was
detected in characteristic punctate cytoplasmic com-
plexes that were completely distinct from the signal for
M, typically found in a focused perinuclear pattern (Fig.
3C). At 12 h p.i., the pattern of p1a-22 with respect to M
was unchanged, remaining completely distinct, and in
dramatic contrast to the colocalization of hel and N with
M at 12 h p.i. The observed separation of p1a-22 from M
was not dependent on cell morphology and was not
affected by syncytia formation.
When cells were probed for p65 and M, p65 was
detected in a pattern identical to that of p1a-22, with
punctate cytoplasmic foci of p65 in a pattern that was
distinct from the perinuclear foci of M at all times of
infection (Fig. 3D). These data confirmed that the p1a-
22/p65-associated membranes were physically distinct
from the hel/N-associated membranes and showed that
the hel/N complexes and the p1a-22/p65 complexes sep-
arate during the course of infection.
Relocalization of hel/N complexes to sites of M
accumulation does not require new protein synthesis
To demonstrate that the colocalization of hel/N com-
plexes with M at late times postinfection was due to
translocation of existing hel/N complexes to sites of M
accumulation rather than to de novo synthesis of hel or N
FIG. 5. Hel and M colocalize with ERGIC-p53 at late times of infec-
tion. MHV-infected cells were fixed and permeabilized at 12 h p.i. and
probed for ERGIC-p53 (red in all panels) and hel, M, or p1a-22 (green).
Merged images are shown to the far right with yellow pixels showing
colocalization of red and green signal. (A) hel/ERGIC; (B) M/ERGIC; (C)
p1a-22/ERGIC.
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25TRANSLOCATION OF MHV REPLICASE PROTEINSat a new location, we analyzed the effect of the transla-
tion inhibitor cycloheximide on hel/N relocalization (Fig.
4). A 100 mg/ml concentration of cycloheximide has been
previously determined to be sufficient for inhibition of
gene 1 translation in coronavirus-infected cells (Kim et
al., 1995; Perlman et al., 1987; Sawicki and Sawicki,
986). When infected cells were incubated with cyclo-
eximide beginning at 5.5 h p.i. and continuing through-
ut the remainder of infection, extensive colocalization of
el or N with M was still observed at 12 h p.i. (Figs. 4A
nd 4B). In contrast, p1a-22 and p65 remained distinct
rom M at 12 h p.i. in the presence of cycloheximide (Figs.
C and 4D). These experiments demonstrated that the
bserved colocalization of the hel/N complexes from 8 to
2 h p.i. was due to translocation of membrane-associ-
ted proteins translated prior to 5.5 h p.i. This experiment
lso showed that the process of translocation did not
equire ongoing cellular or viral protein synthesis be-
ween 5.5 and 12 h p.i.
el and M colocalize on endoplasmic
eticulum–Golgi–intermediate compartment
embranes at late times of infection
Coronavirus budding is known to take place in the
ndoplasmic reticulum–Golgi–intermediate compart-
ent (ERGIC) (Klumperman et al., 1994; Krijnse-Locker et
l., 1994). We therefore wanted to know whether the
RGIC was the site of colocalization of M with the hel/N
omplex. We used an antibody directed against ERGIC-
53, a specific marker for the ERGIC (Hauri et al., 2000),
o determine whether the ERGIC was the site of colocal-
zation of hel/N complexes with M. DBT cells were in-
ected for 5.5 h before the medium was changed to
MEM containing cycloheximide. Infected cells were
ixed at 12 h p.i. and probed for ERGIC-p53 and either hel
r M (Figs. 5A and 5B). At 12 h p.i. both hel and M
olocalized with ERGIC-p53. In contrast, when cells were
ual-labeled for p1a-22 and ERGIC-p53, p1a-22 was en-
irely distinct from ERGIC-p53 (Fig. 5C). These results
howed that the hel/N complexes, but not the p1a-22/p65
omplexes, were translocated to the MHV budding com-
artment in the ERGIC.
DISCUSSION
Positive-strand RNA viruses are known to organize
eplication complexes on the surface of cytoplasmic
embranes using a variety of mechanisms and cytoplas-
ic organelles to organize their replication complexes
Candurra et al., 1999; Froshauer et al., 1988; Nejmeddine
et al., 2000; Schlegel et al., 1996; Westaway et al., 1997).
However, several important areas of the cell biology of
replication complex formation and function of positive-
strand RNA viruses have remained undefined. One area
critical to understanding virus–host interaction duringreplication is the changes that occur in viral replication
complexes over time. This is important since biochemi-
cal and physical changes in the replication complexes
may correlate with different stages of RNA transcription,
replication, encapsidation, or assembly. The second
question concerns the relationship of replication com-
plexes to sites of virus assembly in cells. This is a
particularly intriguing area since several positive-strand
RNA viruses, such as the alphaviruses and flaviviruses,
target replication complexes to sites that are distinct
from those of virus assembly, raising questions about
how newly synthesized RNA is delivered to these sites of
assembly. Therefore, understanding the dynamic virus–
host interactions is critical to a comprehensive under-
standing of replication.
In this study we have shown that there are temporal
changes in the organization, association, and localiza-
tion of the membrane/protein/RNA complexes that to-
gether comprise the putative mouse hepatitis virus rep-
lication complexes. Our previous confocal and biochem-
ical experiments strongly argued that the membrane/
protein complexes active in MHV RNA synthesis were in
fact composed of two independent membrane popula-
tions containing distinct replicase (gene 1) proteins (Bost
et al., 2000; Sims et al., 2000). The experiments in this
study have demonstrated the physical separation of the
hel/N and p1a-22/p65 complexes and relocalization of
the hel/N complex during the course of infection, thus
confirming in a compelling fashion that the MHV repli-
cation complexes are composed of physically distinct
but closely associated membrane/protein populations.
To our knowledge this is the first description of a multi-
partite replication complex with distinct temporal pat-
terns of association and separation. The results have
important implications for our study and understanding
of the regulation of coronavirus RNA synthesis and virion
assembly.
Localization of the hel/N complex and viral RNA
Our results show that the localization of both hel and
N changes during the course of infection, characterized
by decreasing interaction with the p1a-22/p65 complex
and increasing colocalization with a marker for virion
assembly, the structural protein M. Since we previously
demonstrated that hel, N, p28, and newly synthesized
viral RNA segregate to the same membrane population
(Sims et al., 2000), our present study strongly suggests
that viral RNA and the p28 protein are also delivered with
hel and N to the ERGIC. We have detected MHV RNA
metabolically labeled with BrUTP at sites entirely distinct
from the p1a-22/p65 complex at 6 to 8 h p.i. (data not
shown); however, it has been more difficult to directly
show the translocation of newly synthesized genomic
RNA. We presume this is because it would require shut-
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26 BOST, PRENTICE, AND DENISONoff of all viral RNA synthesis at 5–6 h p.i., tracking of RNA
synthesized before inhibition of RNA synthesis, and sta-
bility of RNA over a 3- to 6-h period. Further, it has been
reported that viral nucleocapsids are rapidly incorpo-
rated into virions and exported from the cell, so that
localizing amounts of RNA necessary for detection at late
times may be difficult. We are currently using a combi-
nation of metabolic labeling, RNA fluorescence in situ
hybridization, and immuno-EM approaches to investigate
the specific association of genomic RNA with the hel/N
complex, as well as the predicted translocation of viral
nucleocapsids for assembly over time.
Continued protein expression is not required for
separation and translocation of the hel/N complex
Relocalization of the hel/N complexes occurred in the
presence of inhibitory concentrations of cycloheximide,
demonstrating that continued viral or cellular protein
synthesis after 5.5 h p.i. was not required for separation
or translocation of the complexes. Since addition of cy-
cloheximide has been shown to result in the rapid shutoff
of viral RNA synthesis when added at any time during
infection (Kim et al., 1995; Perlman et al., 1987; Sawicki
nd Sawicki, 1986; Shi et al., 1999), our experiments
urther suggest that continued RNA synthesis after 5.5 h
ay not be required for hel/N complex translocation. The
eparation and translocation observed may therefore be
he result of viral or cellular processes or signals that are
lready under way prior to inhibition of viral protein or
NA synthesis. This is a reasonable possibility since
HV RNA synthesis also begins to decline by 6–8 h p.i.
n untreated cells (Kim et al., 1995). It should be possible
o answer this question by investigating inhibition of viral
r cellular protein or RNA synthesis at earlier times in
nfection.
echanisms of translocation of hel/N complexes
Another question that has arisen from our experiments
s the mechanism of translocation of the hel/N com-
lexes. We have previously reported that the membranes
ith which hel, N, RNA, and p28 segregate contain en-
ymatic activity found in membranes of the endoplasmic
eticulum (ER) (NADPH–cytochrome C reductase) (Sims
t al., 2000). If the ER is the sole or major membrane
omponent of hel/N complexes, then “normal” ER-to-
RGIC trafficking pathways would provide an estab-
ished mechanism that MHV might exploit to deliver
eplication products to sites of assembly. It is interesting
hat the presence of distributed punctate ERGIC or “ER
xit sites” has been recently described (Rossanese et al.,
999) and that the pattern of expression of these sites is
eminiscent of the MHV replication complexes at 5 to 6 h
.i. (Bost et al., 2000; Shi et al., 1999; van der Meer et al.,
999). ER-to-ERGIC movement appears to be an ongoing
o
arocess of migration of ER “packets” along microtubular
ighways in normal cells except in the presence of
pecific inhibitors (Thyberg and Moskalewski, 1999).
hus the temporal change in hel/N complex association
ith the p1a-22/p65 complex and the rather specific
ransition to separation and translocation suggest a reg-
lated process. Since new virus is detected in the su-
ernatant medium of MHV-infected DBT cells before the
hange in hel/N complex localization is observed, it is
ikely that translocation of smaller packets of hel/N com-
lexes is occurring earlier than 6 h p.i. The prominent
lteration in hel/N complex localization detected in this
tudy may represent a more comprehensive transition
rom replication to assembly.
It is also possible that endosome-to-ERGIC trafficking
ould account for some or all hel/N complex transloca-
ion, since late endosomes have been implicated as
ites for viral RNA synthesis (van der Meer et al., 1999),
nd markers for endosomes have been detected in gra-
ient fractions containing the hel/N/p28/RNA complexes
Sims et al., 2000). There is no precedent for direct
rafficking from endosomes to ERGIC; rather it is thought
hat endosome-to-ER trafficking occurs via retrograde
ovement through the Golgi. Specifically, Rab 9-medi-
ted movement from endosomes to the trans-Golgi net-
ork (TGN) results in fusion of endosomes with the TGN
Lombardi et al., 1993). The endosome cargo is then
vailable for movement by retrograde transport mecha-
isms from the TGN to the ERGIC (White et al., 1999).
dentification of the membranes in the hel/N complex will
e useful as a basis for investigating specific pathways
f cellular transport.
mplications of hel/N complex translocation for virion
ssembly
Delivery of the hel/N complexes to sites of virus
ssembly also might serve an important function in
ssembly. In addition to serving as a potential mech-
nism for delivery of newly synthesized RNA, hel/N
igration could serve as a retention signal for M in the
RGIC. Narayanan et al. (2000) have recently reported
pecific M–N interactions at 8 h p.i. in a pre-Golgi
ompartment; however, they were unable to re-create
his interaction in cells overexpressing M and N. They
peculated that a MHV-specific action is required for
his interaction (Narayanan et al., 2000). Our experi-
ents would support the conclusion that the missing
HV action is the translocation of the hel/N complex.
dditionally, it was reported that N was associated
ith all genomic and subgenomic RNA species, but
nly N in association with genome length RNA was
ble to be coimmunoprecipitated with M (Narayanan
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27TRANSLOCATION OF MHV REPLICASE PROTEINSet al., 2000). Thus hel/N complex translocation pro-
ides an attractive model for regulation of packaging
f complete viral nucleocapsids.
odel of coronavirus replication complex shuttling to
ites of virion assembly
The events between coronavirus entry and assembly
ppear to involve a dynamic process of changing pro-
ein/membrane interactions. Based on our data, we pro-
ose a model in which virus–cell interactions may be
ivided into temporally distinct stages (Fig. 6). The early
tage (0 to 6 h p.i.) is characterized by gene 1 replicase
rotein expression, maturation, and targeting to bio-
hemically separate but intimately associated mem-
rane populations in discrete foci within the cell cyto-
lasm. These interacting membrane populations are
ites for viral RNA synthesis, with the timing of maximal
etection of the interacting membrane/protein com-
lexes corresponding to times of maximal viral RNA
ynthesis. During this stage, newly synthesized viral RNA
ssociates specifically with the membrane population
ontaining hel, N, and p28 (Bost et al., 2000; Denison et
l., 1998; Kim et al., 1995; Shi et al., 1999; van der Meer et
l., 1999). Finally, during the early stage, M protein can be
etected in perinuclear and cytoplasmic foci discrete
rom the putative replication complexes. During the in-
ermediate stage (6 to 8 h p.i.), the translocation of hel/N
omplexes to the ERGIC is first observed. The late stage
8 to 12 h p.i.) is characterized by extensive separation of
he hel/N complexes from the p1a-22/p65 complexes
nd colocalization of hel/N complexes with the ERGIC
nd M. This late stage is temporally associated with
ecreasing rates of new viral RNA synthesis and maxi-
al rates of new virus production. We speculate that
hese temporal associations are not coincidental but
ather reflect specific transitions in the virus life cycle
FIG. 6. Model of coronavirus replication complex separation and
translocation of hel/N complexes to ERGIC. See text for discussion.rom replication to assembly. This would further indicate
hat the association of p1a-22/p65 complexes with hel/Nomplexes is required for RNA synthesis and that the
eparation and translocation of the hel/N complexes
esult in both shutoff of RNA synthesis and delivery of
iral nucleocapsids to sites of virion budding.
The results of this study will provide the foundation
or studies of the mechanisms of replication complex
ormation, function, and translocation. The link be-
ween stages of replication and detectable virus cell
nteractions should allow us to define viral and cellular
roteins and pathways involved in each stage of MHV
eplication.
MATERIALS AND METHODS
ntibodies
The anti-hel (B1), anti-p1a-22, and anti-p65 antisera
ere generated in rabbits and have been previously
ublished (Denison et al., 1999; Lu et al., 1998; Sims et
l., 2000). The anti-M (J.1.3) and anti-N (J.3.3) monoclonals
ere provided by John Fleming (University of Wisconsin,
adison), and anti-ERGIC was obtained from Hans-Peter
auri (University of Basel, Switzerland).
irus infection and confocal immunofluorescence
ssays.
DBT cells on glass coverslips were mock-infected or
nfected with MHV A59 (Hirano et al., 1976) at a multi-
licity of infection of 10 plaque-forming units per cell.
nfections were performed at 37°C in Dulbecco’s modi-
ied Eagle’s medium (DMEM) containing 6% fetal calf
erum (FCS). In all experiments using cycloheximide, the
irus inoculant was removed from the cells at 5.5 h p.i.
nd replaced with DMEM containing 6% FCS and 100
mg/ml cycloheximide (Sigma). DMEM in parallel mock-
infected wells was also replaced with cycloheximide-
containing medium at 5.5 h p.i. At the times indicated,
cells were washed in 13 Tris and fixed in 220°C 100%
methanol. Cells were then rehydrated in phosphate-buff-
ered saline (PBS) containing 5% bovine serum albumin
(BSA). For dual-labeling studies using one primary anti-
body derived from rabbit and the other from mouse,
primary antisera were combined in diluent containing
PBS with 2% goat serum, 1% BSA, and 0.05% NP-40 and
were incubated with the rehydrated cells for 1 h at room
temperature. Primary polyclonal sera were all used at a
final 1:100 dilution for each antibody, and the monoclonal
anti-N (J.3.3), anti-M (J.1.3), and anti-ERGIC antibodies
were each diluted 1:500. After being washed in PBS/1%
BSA/0.05% NP-40, cells were incubated at room temper-
ature for 1 h with a 1:1000 dilution of anti-rabbit and/or
anti-mouse secondary antisera conjugated to Alexa 488
or Alexa 546 dyes (Molecular Probes). The final antibody
incubation for all cells was followed by washing in
(
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28 BOST, PRENTICE, AND DENISONPBS/1% BSA/0.05% NP-40. Cells were then washed with
PBS, rinsed with H2O, and mounted in Aquapolymount
Polysciences, Inc.) on glass slides. Immunofluores-
ence was detected at 488 and 543 nm using a 403 oil
mmersion objective on the Zeiss LSM 410 confocal mi-
roscope in the Shared Imaging Resource of the Vander-
ilt Ingram Cancer Center. Differential interference con-
rast (DIC) images were obtained using the 488-nm laser.
or images shown in color, red and green were artifi-
ially assigned to the grayscale images using the hue-
aturation option in Adobe Photoshop 5.0.
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